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Abstract
Background: The SH3 and cysteine-rich domain 3 (Stac3) gene is specifically expressed in the skeletal muscle. Stac3
knockout mice die perinatally. In this study, we determined the potential role of Stac3 in postnatal skeletal muscle
growth, fiber composition, and contraction by generating conditional Stac3 knockout mice.
Methods: We disrupted the Stac3 gene in 4-week-old male mice using the Flp-FRT and tamoxifen-inducible
Cre-loxP systems.
Results: RT-qPCR and western blotting analyses of the limb muscles of target mice indicated that nearly all Stac3
mRNA and more than 70 % of STAC3 protein were deleted 4 weeks after tamoxifen injection. Postnatal Stac3 deletion
inhibited body and limb muscle mass gains. Histological staining and gene expression analyses revealed that postnatal
Stac3 deletion decreased the size of myofibers and increased the percentage of myofibers containing centralized
nuclei, with no effect on the total myofiber number. Grip strength and grip time tests indicated that postnatal Stac3
deletion decreased limb muscle strength in mice. Muscle contractile tests revealed that postnatal Stac3 deletion
reduced electrostimulation-induced but not the ryanodine receptor agonist caffeine-induced maximal force output in
the limb muscles. Calcium imaging analysis of single flexor digitorum brevis myofibers indicated that postnatal Stac3
deletion reduced electrostimulation- but not caffeine-induced calcium release from the sarcoplasmic reticulum.
Conclusions: This study demonstrates that STAC3 is important to myofiber hypertrophy, myofiber-type composition,
contraction, and excitation-induced calcium release from the sarcoplasmic reticulum in the postnatal skeletal muscle.
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Background
The Stac3 gene, which encodes a protein containing Src
homology 3 and cysteine-rich domains, is expressed
specifically in the skeletal muscle [1]. STAC3 has been
recently identified as a novel regulator of embryonic skel-
etal muscle development and contraction. Stac3 knockout
mice die at birth [1, 2]. Most of the muscle fibers in new-
born Stac3 knockout mice contain centralized nuclei and
disorganized myofibrils [1].
The skeletal muscles from Stac3-deleted mouse fetuses
do not contract, and this is suggested to be due to
defective excitation-contraction (EC) coupling [2]. A
role of STAC3 in EC coupling is further supported by
immunoprecipitation data from zebrafish that suggests
STAC3 interacts with the dihydropyridine receptors
(DHPR) and the ryanodine receptors (RYR) [3] and
immunohistochemical data from mice that indicates
STAC3 co-localizes with DHPR at the T-tubules [2]. A
more recent study demonstrates that STAC3 is essential
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for trafficking of the major subunit of DHPR, DHPRα1s,
also known as Cav1.1 and CACNA1S, into cell membranes
[4]. In vitro studies suggest that STAC3 might be involved
in myoblast differentiation [5, 6]. Mutations in the human
Stac3 gene have been linked to two congenital myopathies,
Native American myopathy [3] and King-Denborough
syndrome [7].
In this study, we determined the potential role of STAC3
in postnatal skeletal muscle growth, fiber composition, and
contraction. We disrupted the Stac3 gene in 4-week-old
mice through the Flp-FRT and Cre-loxP systems [8, 9].
Our study demonstrates that STAC3 is important to fiber
hypertrophy, fiber-type composition, muscle contraction,
and electrostimulation-induced calcium release from the
sarcoplasmic reticulum in the postnatal skeletal muscle.
Methods
Generation of conditional Stac3 knockout mice
The generation of heterozygous Stac3 mutant mice
(Stac3+/−) has been described [1]. The mutant Stac3 al-
lele was inserted with a trapping cassette (SA-βgeo-pA)
flanked by two flippase (Flp) recombinase target sites
(flippase recognition target, FRT) between exons 1 and 2
and two Cre recombinase target sites (loxP) that flanked
exons 2 to 5. Transgenic mice that expressed a Flp re-
combinase (TgFlp) driven by the human beta actin pro-
moter [B6.Cg-Tg(ACTFLPe)9205Dym/J] and transgenic
mice (TgCre) that carried a tamoxifen-inducible Cre re-
combinase driven by the chicken beta actin promoter/
enhancer coupled with the cytomegalovirus immediate-
early enhancer [B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J] were
purchased from the Jackson Laboratory (Bar Harbor, ME)
[10]. When purchased, these transgenic mice had been
backcrossed onto the C57BL/6J background for at least
five generations. A Stac3+/− mouse was mated to a TgFlp
mouse to generate offspring (Stac3+/fl) in which the
mutant Stac3 allele was converted to a pre-conditioned
wild-type allele. Two Stac3+/fl mice were mated to gener-
ate Stac3fl/fl mice in which both Stac3 alleles were con-
verted to the pre-conditioned alleles. A Stac3fl/fl mouse
was crossed with a TgCre mouse to generate Stac3+/flTgCre
mice. One Stac3+/flTgCre mouse and one Stac3fl/fl mouse
were mated to generate Stac3fl/flTgCre mice. Male Stac3fl/fl,
Stac3+/flTgCre, and Stac3fl/flTgCre mice at 4 weeks of age
were injected intraperitoneally with tamoxifen (Sigma-
Aldrich, St. Louis, MO) dissolved in corn oil at a daily
dose of 75 mg/kg body mass for five consecutive days to
activate the transcription of the Cre transgene and hence
to delete the Stac3fl allele. All mice were kept on a 12-h
light/12-h dark cycle at 23 °C. Mice had ad libitum access
to food (rodent diet 2918, Harlan, Indianapolis, IN)
and water. All protocols involving mice were approved by
the Virginia Tech Institutional Animals Care and
Use Committee.
Genotyping
Mice were genotyped by PCR of genomic DNA isolated
from ear notches followed by gel electrophoresis. Gen-
omic DNA was isolated using the DNeasy Blood & Tissue
Kit (Qiagen, Hilden, Germany). Initial PCR products were
confirmed by DNA sequencing. The Flp and Cre trans-
genes were identified using primer pairs suggested by the
Jackson Laboratory. The sizes of PCR products from these
two pairs of primers were expected to be 725 and 100 bp,
respectively. The wild-type and trapped Stac3 alleles were
identified by PCR using primers F1 and R1. These two
primers amplified a 317-bp product from the wild-type
Stac3 allele and a 344-bp product from the trapped Stac3
allele. The Flp-cleaved Stac3 allele (Stac3fl) was confirmed
by PCR using primers F2 and R2. These two primers were
designed to flank the trapping cassette to generate a
451-bp product from the Stac3fl allele, a 259-bp product
from the wild-type Stac3 allele, and no product from the
trapped Stac3 allele. The Cre-recombined Stac3fl allele
(Stac3flΔ) was confirmed by PCR using primers F2 and R1,
which amplified a 2478-bp product from the Stac3fl allele,
a 2259-bp product from the wild-type Stac3 allele, and a
530-bp product unique to the Stac3flΔ allele. Sequences of
all primers used in this study are presented in Additional
file 1: Table S1.
Reverse transcription-quantitative polymerase chain
reaction (RT-qPCR)
Total RNA from mouse tissue samples was extracted
using the TRI reagent (Molecular Research Center, Inc.,
Cincinnati, OH), following the manufacturer’s instruc-
tions. Concentrations of RNA samples were determined
using a NanoDrop 2000 Spectrophotometer (Thermo
Fisher Scientific, Pittsburgh, PA). First-strand cDNA
synthesis was performed using random primers and
ImProm-II reverse transcriptase (Promega Corp., Madison,
WI). Quantitative PCR was performed using SyberGreen
PCR Master Mix (Life Technologies Corp., Carlsbad, CA)
and gene-specific primers (Additional file 1: Table S1) on a
CFX96 Touch Real-Time PCR Detection System (Bio-Rad
Laboratories, Inc., Hercules, CA). Primers were designed
using the Primer3 software (MIT, Cambridge, MA).
The specificity of all primers was verified by agarose
gel electrophoresis followed by DNA sequencing. The
amplification efficiency of all primers was determined
by analyzing the standard curve of serially diluted
cDNA. The amplification efficiency of the primers
used in this study ranged from 90 to 110 %. The relative
abundance of a mRNA to 18S rRNA was calculated using
the ΔΔCt method [11].
Western blotting analysis
Mouse muscle samples were lysed in radio immuno-
precipitation assay (RIPA) buffer consisting of 25 mM
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Tris-HCl, 150 mM NaCl, 1 % NP-40, 1 % sodium
deoxycholate, 0.1 % SDS, and 1 % protease inhibitors
(Thermo Fisher Scientific) at 4 °C for 30 min. The lysates
were centrifuged at 12,000×g for 15 min at 4 °C. Protein
concentrations in the supernatants were measured
using a BCA Protein Assay Kit (Thermo Fisher Scientific).
For western blotting, 30 μg of total cellular protein were
resolved by 10 % (for STAC3) or 6 % (for CACNA1S
and RYR1) SDS-PAGE followed by transfer to a 0.2 μm
nitrocellulose membrane (Bio-Rad Laboratories). The
membrane was blocked with 5 % non-fat milk in TBST
(20 mM Tris-HCl, 500 mM NaCl, and 0.1 % Tween-20)
at room temperature for 1 h and then incubated with
1:1000 diluted primary antibody at 4 °C overnight. The
membrane was then incubated with 1:20,000 diluted
secondary antibody and visualized with the ODYSSEY
CLx system (LI-COR Biosciences, Lincoln, NE). Following
the detection of the primary target protein, the membrane
was stripped in Restore Western Blot Stripping Buffer
(Thermo Fisher Scientific) and re-probed with the
antibody for beta tubulin (TUBB). The following primary
antibodies were used: CACNA1S (1A, Thermo Fisher
Scientific), RYR1 (34C, DHSB, Iowa City, IA), STAC3
(Proteintech Group, Inc., Chicago, IL), and TUBB (E7,
DHSB). The following secondary antibodies were used:
IRDye goat anti-mouse 800CW and IRDye goat anti-rabbit
800CW (LI-COR).
Hematoxylin and eosin staining
The extensor digitorum longus (EDL) and soleus (SOL)
muscles from the right hindlimbs of mice were charac-
terized. Following dissection, a 5-mm-long segment was
cut from the middle of each muscle, immersed in
optimal cutting temperature compound on a cork sheet,
and frozen immediately in isopentane pre-cooled in li-
quid nitrogen. The samples were then left in a Leica CM
1800 cryostat at −18 °C for 20 min for thermal adapta-
tion. Cross-sections of 8 μm were cut and mounted on
Fisher Superfrost Plus slides (Thermo Fisher Scientific)
for subsequent assays. Hematoxylin and eosin staining
was performed as described previously [1]. Stained sec-
tions were imaged with an Eclipse TS100 microscope
(Nikon Corp., Tokyo, Japan).
Myosin-ATPase and nicotinamide adenine dinucleotide-
tetrazolium reductase (NADH-TR) staining
Myosin-ATPase and NADH-TR staining of the EDL and
SOL sections prepared above were conducted as de-
scribed previously [12]. Briefly, for myosin-ATPase
staining, muscle sections were pre-incubated for 5 min
in a sodium barbital buffer containing 20 mM sodium
barbital and 36 mM CaCl2 at pH 4.21 and then incu-
bated for 55 min in a sodium barbital buffer containing
3.5 mM ATP, 20 mM sodium barbital, and 18 mM
CaCl2 at pH 9.45. The sections were rinsed in 1 %
CaCl2 for 3 × 1 min and then immersed in 2 % CoCl2
for 2 min. The sections were then stained with 1 %
(NH4)2S for 20 s followed by five rinses with ddH2O.
Stained sections were dehydrated in 50, 70, 80, 90,
and 100 % ethanol, cleared in xylene, and then
mounted in 50 % xylene and 50 % Canada balsam
(Thermo Fisher Scientific) mixture. The activity of
NADH-TR in the muscle sections was determined by
incubating the sections at 37 °C for 10 min and then
with 1 mg/ml nitroblue tetrazolium and 0.4 mg/ml β-
NADH (Sigma-Aldrich) in 50 mM Tris-HCl buffer,
pH 7.3, at 37 °C for 30 min. After 5 × 5 min washes
in a graded acetone series (30, 60, 90, 60, and 30 %),
the sections were washed with ddH2O, mounted in pro-
long gold mounting medium (Invitrogen), cover-slipped,
and imaged with an Eclipse TS100 microscope (Nikon
Corp.).
Grip strength and grip time tests
Grip strength and grip time were measured weekly at
approximately 9:00 a.m. Grip strength was tested
using a digital mouse grip strength meter (AMETEK,
Inc. Berwyn, PA). The mouse was allowed to grip a
wire mesh grid with its front paws and then was gently
pulled away by its tail until it released the grid. This was
repeated three times, and the mouse was allowed to rest
for 5 min between two consecutive tests. The maximum
force (mN) generated by each pull was recorded by a force
transducer attached to the grid, and values from three
pulls were averaged for each mouse. Grip time was
determined using a coarse metal wire with a 2 mm
diameter. The mouse was allowed to hold the wire using
its front paws. The time from initial grip to release was
recorded as grip time. Data from tests in which the mouse
was unwilling to hold the wire and dropped off con-
sciously were discarded. The grip time test was repeated
at least three times with 5 min of rest between two
consecutive tests. Grip time from three successful tests
was averaged for each mouse. The mouse’s motivational
or cardiovascular status could affect the measured grip
strength or time, and these statuses were not evaluated in
these tests.
Muscle contractile tests
Fast-twitch EDL and slow-twitch SOL muscles were
excised from euthanized mice at 8 weeks of age, i.e.,
4 weeks after tamoxifen injection. The isolated muscles
were incubated at 30 °C in an oxygenated (95 % O2 and
5 % CO2) physiological salt solution (PSS) as previously
described [13]. Non-absorbable braided silk suture (4-0)
was tied to the distal and proximal tendons at the myo-
tendinous junctions. Muscles were then fixed between a
clamp and the arm of a Dual-Mode Servomotor System
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(300B, Aurora Scientific Inc., Aurora, Ontario, Canada)
at a resting tension of 1.0 g which was maintained by a
stepper motor. One EDL muscle and one SOL muscle
from the same mouse were tested under the same treat-
ment conditions at the same time. The servomotor arm
and stepper motor were controlled by Dynamic Muscle
Control software (DMC Version 4.1.6, Aurora Scientific)
to obtain the tension output data.
The stimulated muscle protocol consisted of three
steps. In step 1, the stimulated muscles were subjected
to three isometric twitches and tetani (150 Hz) spaced
1 min apart. In step 2, after a 10-min quiescent period,
the muscles were subjected to a force-frequency proto-
col at electrical stimulation frequencies of 1, 30, 50, 80,
100, and 150 Hz. Stimulation frequencies were spaced
1 min apart and were delivered as 200-μs square wave
pulses, at 20 V. In step 3, after 5 min of rest, the stepper
motor was turned off, the PSS-only buffer drained, and
fresh PSS buffer containing 25 mM caffeine was added
to the EDL and SOL muscle baths. At the end of each
experiment, after a 10-min washout with PSS, each
muscle was gently blotted dry on a Kimwipe; muscle
mass was determined to the nearest 0.1 mg using an
A-200D electronic analytical balance (Denver Instruments,
Denver, CO).
Tension output profiles were analyzed using the
Dynamic Muscle Analysis software (DMA Version 3.2,
Aurora Scientific) to determine contractile properties,
including peak tension, time to peak tension (TPT), and
half-relaxation time (HRT). Muscle cross-sectional area
(CSA) was determined as previously described [14].
Twitch and tetanic tensions were normalized to muscle
CSA to obtain twitch and tetanic stress (mN/mm2).
Single myofiber isolation
Flexor digitorum brevis (FDB) muscles were isolated
from 8-week-old mice and digested in minimum essen-
tial medium (MEM) solution containing 10 % fetal bo-
vine serum (FBS), 1 % penicillin-streptomycin, and 0.2 %
collagenase type 2 (Worthington Biochemical Corp.,
Lakewood, NJ) for 4 h at 37 °C in a tissue culture incu-
bator (5 % CO2). The muscle samples were then gently
triturated with plastic Pasteur pipettes into a 24-well
plate with MEM solution containing 10 % FBS and 1 %
penicillin-streptomycin. Single muscle fibers were ob-
tained by trituration. Subsequently, fibers were main-
tained in MEM solution with 10 % FBS at 37 °C until
used for EC coupling assessment.
EC coupling assessment in single myofibers
Single muscle fibers were loaded with Fura-4F AM for
15 min. The Fura-4F ratio was measured in response to
electrical stimulation as an index of [Ca2+]i. Fibers
loaded with Fura-4F were placed in a stimulation
chamber containing parallel electrodes and the chamber
was positioned on a Nikon TiU microscope stage.
Muscle fibers were continuously perfused with a stimu-
lating Tyrode solution (121.0 mM NaCl, 5.0 mM KCl,
1.8 mM CaCl2, 0.5 mM MgCl2, 0.4 mM NaH2PO4,
24.0 mM NaHCO3, and 5.5 mM glucose) with 0.2 % FBS
[15]. This solution was bubbled with 95 % O2 and 5 %
CO2 to maintain a pH of 7.3 [15]. Levels of [Ca
2+]i were
assessed by the Fura-4F fluorescence ratio using an
IonOptix HyperSwitch system with a dual excitation,
single emission filter set for Fura-4F (excitation 340 and
380 nm; emission 510 nm). Signals were captured and
analyzed using the IonWizard software (IonOptix).
Global Fura-4F ratio was measured in the muscle fibers
using trains of stimuli at 10, 30, 50, 70, and 100 Hz for
350 ms with fibers resting 1 min between frequencies.
Peak Fura-4F ratios at each frequency were determined
by the average ratio in the last 100 ms of the 350-ms
tetanus when Ca2+ Fura-4F should be at a steady
state. All single muscle fibers were evaluated at room
temperature.
Statistics
Student’s t test was used to determine the statistical
significance of the differences between two groups.
ANOVA followed by Tukey’s test was used to examine
the statistical significance of differences between more
than two groups. A difference was considered statisti-
cally significant when P < 0.05. All data were presented
as mean ± standard error of the mean (SEM).
Results
Postnatal deletion of the Stac3 gene in mice
The original mutant Stac3 allele contained two Frt sites
between exons 1 and 2 and two loxP sites that flanked
exons 2 and 5 (Fig. 1a). By crossing Stac3+/− mice first
with mice expressing the Flp recombinase (TgFlp) and
then mice expressing the tamoxifen-inducible Cre re-
combinase (TgCre), we generated mice with the following
genotypes: Stac3fl/flTgCre, which were homozygous for
the floxed Stac3 allele and carried the Cre recombinase
transgene; Stac3+/flTgCre, which were heterozygous for
the floxed Stac3 allele and carried the Cre recombinase
transgene; and Stac3fl/fl, which were homozygous for the
floxed Stac3 allele but did not carry the Cre recombinase
transgene. We confirmed these genotypes by PCR of
genomic DNA from these mice (Fig. 1a, b).
We injected male Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/
flTgCre mice at 4 weeks of age with tamoxifen for five con-
secutive days to induce the expression of Cre recombinase
(Fig. 1a). RT-qPCR analyses of the hindlimb and forelimb
muscles from these mice at 8 weeks of age, i.e., 4 weeks
after tamoxifen injection, revealed that Stac3 mRNA was
nearly absent in Stac3fl/flTgCre mice compared to Stac3fl/fl
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mice (Fig. 2a, P < 0.05). Stac3 mRNA expression in 8-
week-old Stac3+/flTgCre mice was reduced by 50 % com-
pared to that in 8-week-old Stac3fl/fl mice, but the differ-
ence was not statistically significant (Fig. 2a). Western
blotting analyses revealed that STAC3 protein expression
in hindlimb and forelimb muscles was reduced by more
than 70 % in 8-week-old Stac3fl/flTgCre mice compared to
8-week-old Stac3fl/fl mice (Fig. 2b c, P < 0.05). STAC3
protein expression in the forelimb muscles of 8-week-old
Stac3+/flTgCre mice was reduced by approximately 50 %
compared to that in 8-week-old Stac3fl/fl mice (Fig. 2b, c,
P < 0.05). STAC3 protein expression in the hindlimb
muscles was not different between 8-week-old Stac3+/flTgCre
and Stac3fl/fl mice (Fig. 2b, c). Overall, these analyses
Fig. 1 Generation of conditional Stac3 knockout mice. a Schematic representation of the process of generating conditional Stac3 knockout mice.
The original mutant Stac3 allele contained a “trapping cassette” between Stac3 exons 1 and 2 and a loxP site between exons 5 and 6. Crossing
heterozygous Stac3 mutant mice with mice expressing the Flp recombinase caused the trapping cassette to be deleted at the two FRT sites and
hence converted the mutant Stac3 allele to a floxed allele, i.e., a pre-conditional wild-type allele. Crossing mice bearing the floxed Stac3 allele with
mice expressing the Cre recombinase caused exons 2 to 5 flanked by the loxP sites to be deleted and hence inactivated the Stac3 gene. In the
Cre recombinase transgenic mice used in this study, the Cre gene is located downstream of a tamoxifen-inducible chicken beta actin promotor.
Arrows labeled with F1, R1, F2, and R2 indicate the locations of PCR primers for genotyping. b Representative gel images of genotyping. Genotypes
of Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice before and 4 weeks after tamoxifen injection were identified by PCR of genomic DNA followed by gel
electrophoresis. Names of PCR primers or target genes are indicated on the right of gel images and sizes of expected PCR products on the
left of gel images. WT wild type
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demonstrated that nearly all Stac3 mRNA and the majority
of STAC3 protein were ablated by tamoxifen-induced Cre
recombinase in Stac3fl/flTgCre mice.
Postnatal Stac3 deletion reduced body and muscle growth
From 4 to 8 weeks of age, Stac3fl/flTgCre mice gained
approximately 2 g in body mass while control mice
(Stac3+/flTgCre and Stac3fl/fl) gained approximately 5 g (Fig. 3a).
The masses of the EDL, tibialis anterior (TA), and SOL mus-
cles from 8-week-old Stac3fl/flTgCre mice were nearly 30 % less
than those from 8-week-old Stac3+/flTgCre or Stac3fl/fl mice
(Fig. 3b, P < 0.05). The masses of the heart and liver
were not different between 8-week-old Stac3fl/flTgCre
mice and Stac3+/flTgCre or Stac3fl/fl mice (data not shown).
Neither body mass (Fig. 3a) nor individual muscle masses
(Fig. 3b) was different between 4-week-old Stac3fl/flTgCre
and Stac3+/flTgCre or Stac3fl/fl mice. These data ruled out
the possibility that differences in body and muscle masses
between these mice at 8 weeks of age were due to differ-
ences in their initial genotypes.
Postnatal Stac3 deletion decreased muscle size and
increased the number of myofibers with centralized nuclei
Decreased muscle size and the presence of centralized
nuclei were evident in the Stac3fl/flTgCre EDL compared
to the other genotypes (Fig. 4a). Total myofiber numbers
in EDL muscles of 8-week-old Stac3fl/fl, Stac3+/flTgCre,
and Stac3fl/flTgCre mice did not differ (Fig. 4b). The
Fig. 2 Validation of Stac3 knockout. a Analysis of Stac3 mRNA expression. Stac3 mRNA in the hindlimb and forelimb muscles of Stac3fl/fl, Stac3+/flTgCre,
and Stac3fl/flTgCre mice at 8 weeks of age, i.e., 4 weeks after tamoxifen injection, was quantified by RT-qPCR. Bars not sharing the same letter labels are
different (P < 0.05, n = 4 mice). b Images from western blotting analyses of STAC3 protein in hindlimb (HL) and forelimb (FL) skeletal muscles of
8-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. β-tubulin (TUBB) protein was used as a loading control. c Quantification of STAC3 protein
band intensity. The expression level of STAC3 protein is normalized to that of β-tubulin in the same sample. Bars not sharing the same letter labels are
different (P < 0.05, n = 3 mice)
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average CSA of EDL myofibers in 8-week-old Stac3fl/
flTgCre mice was smaller than that in 8-week-old
Stac3+/flTgCre mice, and the latter was smaller than
that in 8-week-old Stac3fl/fl mice (Fig. 4c, P < 0.05).
The distribution of CSA of 8-week-old Stac3fl/flTgCre
EDL myofibers was skewed to the left compared to that
of 8-week-old Stac3+/flTgCre or Stac3fl/fl EDL myofibers
(Fig. 4d). The EDL muscle in 8-week-old Stac3fl/flTgCre
mice contained more myofibers with centralized nuclei
than that in Stac3+/flTgCre or Stac3fl/fl mice (Fig. 4e, P <
0.05). Similar differences in myofiber CSA and number of
myofibers with centralized nuclei were observed for the
SOL muscles between Stac3fl/fl TgCre and Stac3fl/fl or
Stac3+/flTgCre mice (Fig. 5a–e). However, none of these
differences were observed for the EDL or SOL muscles
from Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice at
4 weeks of age, i.e., before tamoxifen injection (Additional
file 2: Figure S1 and Additional file 3: Figure S2).
Postnatal Stac3 deletion increased the percentage of type
I and oxidative myofibers
Body musculature of 8-week-old Stac3fl/flTgCre mice ap-
peared to be redder than those from 8-week-old Stac3fl/fl
mice (Fig. 6). Based on myosin-ATPase staining at pH
4.21 (Fig. 7a), the 8-week-old Stac3fl/flTgCre EDL muscle
contained a higher percentage of type I fibers and a
lower percentage of type II (IIa, b, and x) fibers than the
8-week-old Stac3fl/fl or Stac3+/flTgCre EDL muscle
(Fig. 7b, P < 0.05). The percentage of type I or type II fi-
bers was not different between the 8-week-old Stac3fl/fl
and Stac3+/flTgCre EDL muscles (Fig. 7b). The percentage
of type I or type II myofibers was not different between
the 8-week-old Stac3fl/flTgCre and Stac3fl/fl or Stac3+/flTgCre
SOL muscle (Fig. 7c). The percentage of type I or type II
fibers in the EDL or the SOL muscle was not differ-
ent between 4-week-old Stac3fl/flTgCre and Stac3fl/fl or
Stac3+/flTgCre mice (Additional file 4: Figure S3).
Based on NADH-TR staining (Fig. 8a), the 8-week-old
Stac3fl/flTgCre EDL and SOL muscles contained higher
percentages of myofibers that stained darker, meaning
greater oxidative capacity, than the 8-week-old Stac3fl/fl or
Stac3+/flTgCre EDL and SOL muscles (Fig. 8b, P < 0.05).
Neither NADH-TR staining of the EDL muscle nor that of
the SOL muscle was different between 4-week-old Stac3fl/
flTgCre and Stac3fl/fl or Stac3+/flTgCre mice (Additional
file 5: Figure S4).
Postnatal Stac3 deletion increased the expression of
genes marking type I fibers and developing muscle
We compared the expression levels of genes Actn3, Myh1,
Myh2, Myh4, and Tnnt3 that are markers of type II myofi-
bers and the expression levels of genes Mb, Mef2c, Myh7,
Ppargc1a, and Tnnt1 that are markers of type I myofibers,
in the hindlimb muscles of 8-week-old Stac3fl/flTgCre,
Stac3+/flTgCre, and Stac3fl/fl mice. As shown in Table 1,
four of the five type I fiber marker genes including Myh7,
which is the only myosin heavy chain gene expressed in
type I fibers, were expressed at greater levels in 8-week-
old Stac3fl/flTgCre than in 8-week-old Stac3fl/fl or Stac3
+/flTgCre mice; two of the five type II fiber marker genes in-
cluding Myh4, the predominant myosin heavy chain
expressed in type II fibers, were expressed at lower levels
in 8-week-old Stac3fl/flTgCre than in 8-week-old Stac3fl/fl
or Stac3+/flTgCre mice. Among the five type II fiber
marker genes analyzed, expression of Actn3 mRNA was
greater in 8-week-old Stac3fl/fl TgCre than in 8-week-old
Fig. 3 Body and muscle masses of Stac3fl/fl, Stac3+/flTgCre, and
Stac3fl/flTgCre mice. a Body mass before and after tamoxifen injection.
Tamoxifen injection was initiated on the first day of week 5 of age
(indicated by a black arrow) and continued for 5 days. Body masses
not sharing the same letter labels are different at the same age
(P < 0.05, n = 4 mice). b Masses of EDL, TA, and SOL muscles at 8 weeks
of age. Bars not sharing the same letter labels are different (P < 0.05,
n = 4 mice). c Masses of EDL, TA, and SOL muscles at 4 weeks of age.
The masses of these muscles were not different between 4-week-old
Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. EDL extensor digitorum
longus, TA tibialis anterior, SOL soleus
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Stac3fl/fl or Stac3+/flTgCre mice (Table 1). The Myh3 and
Myh8 genes are typically expressed in fetal and perinatal
muscle or regenerating adult muscle [16, 17]. Both
Myh3 and Myh8 mRNAs were expressed at greater
levels in the 8-week-old Stac3fl/flTgCre than in the 8-week-old
Stac3fl/fl or Stac3+/flTgCre muscles (Table 1).
Postnatal Stac3 deletion reduced muscle strength
Stac3fl/flTgCre mice had weaker grip strength than Stac3fl/fl
mice at each of the 4 weeks following tamoxifen injection
(Fig. 9a, b, P < 0.05). Stac3+/flTgCre mice had weaker grip
strength than Stac3fl/fl mice at the first week after tamoxifen
injection (Fig. 9a, b, P < 0.05). Compared to Stac3fl/fl mice,
Stac3fl/flTgCre mice had shorter grip time at the second,
third, and fourth weeks after tamoxifen injection (Fig. 9c, d,
P < 0.05). Stac3+/flTgCre mice had shorter grip time than
Stac3fl/fl mice at the fourth week after tamoxifen injection
(Fig. 9a, b, P < 0.05). Stac3fl/flTgCre, Stac3+/flTgCre, and
Stac3fl/fl mice did not differ in grip strength or grip time at
4 weeks of age, i.e., before tamoxifen injection (Fig. 9a–d).
Fig. 4 Histological analysis of EDL muscles from 8-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. Cross-sections of EDL muscles were
stained with hematoxylin and eosin. a Representative images of stained EDL sections at ×40 and ×400 magnifications. Scale bars: 100 μm for ×40
and 10 μm for ×400. Arrows point to myofibers with centralized nuclei. b Average number of myofibers per cross-section. This number was not
different between genotypes. c Average cross-sectional area (CSA) of myofibers. d Distribution of myofiber CSA. e Percentage of myofibers containing
centralized nuclei. Bars not sharing the same letter labels are different (P < 0.05, n = 4 mice)
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Postnatal Stac3 deletion reduced electrostimulation- but
not caffeine-induced muscle contraction
We compared the contractile properties of the EDL and
SOL muscles from Stac3fl/fl and Stac3fl/flTgCre mice at
8 weeks of age, i.e., 4 weeks after tamoxifen injection.
The stress-frequency responses to electrostimulation
were more than 50 % smaller in the Stac3fl/flTgCre than
in the Stac3fl/fl EDL and SOL muscles (Fig. 10a, b, P <
0.05). However, for both twitch and tetanic (150 Hz)
stresses, neither time to peak tension (TPT) nor half-
relaxation time (HRT) was different between the Stac3fl/fl
TgCre and Stac3fl/fl EDL or SOL muscle (Additional file 1:
Table S2).
Caffeine induced both the EDL and SOL muscles from
both 8-week-old Stac3fl/fl and Stac3fl/flTgCre mice to con-
tract (Fig. 11a). However, the caffeine-induced maximum
tension in either muscle was not different between the
two genotypes (Fig. 11b). The TPT for caffeine-induced
Fig. 5 Histological analysis of SOL muscles from 8-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. Cross-sections of SOL muscles were
stained with hematoxylin and eosin. a Representative images of stained SOL sections at ×40 and ×400 magnifications. Scale bars: 100 μm for ×40
and 10 μm for ×400. Arrows point to myofibers with centrally located nuclei. b Average number of myofibers per cross-section. This number was
not different between genotypes. c Average CSA of myofibers. d Distribution of CSA of myofibers. e Percentage of myofibers containing centralized
nuclei. Bars not sharing the same letter labels are different (P < 0.05, n = 4 mice)
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contraction in either muscle was also not different
between the two genotypes (Additional file 1: Table S2).
Postnatal Stac3 deletion reduced electrostimulation- but
not caffeine-induced intracellular increase of calcium in
single myofibers
We compared electrostimulation-induced calcium re-
lease from the sarcoplasmic reticulum in single FDB
myofibers from 8-week-old Stac3fl/fl and Stac3fl/flTgCre
mice (Fig. 12a; Additional file 6: Figure S5). Resting
concentration of intracellular calcium was 4 % greater
in Stac3fl/flTgCre than in Stac3fl/fl myofibers (Fig. 12b,
P < 0.05). Frequent electrostimulation increased the
concentration of intracellular calcium in both Stac3fl/fl
and Stac3fl/flTgCre myofibers (Fig. 12b), but the increase
was smaller in Stac3fl/flTgCre than in Stac3fl/fl myofibers
at each of the frequencies tested (Fig. 12b, P < 0.05;
Additional file 6: Figure S5). Caffeine caused an 8 %
increase in the concentration of intracellular calcium in
resting Stac3fl/flTgCre myofibers, but it had no effect on
that in resting Stac3fl/fl myofibers (Fig. 12c, P < 0.05).
Caffeine caused significant increases in the concentra-
tion of intracellular calcium in both Stac3fl/fl and
Stac3fl/flTgCre myofibers that were electrically
Fig. 6 Representative images of body and limb muscles of 8-week-old
Stac3fl/fl and Stac3fl/flTgCre mice immediately after euthanasia. Note that
the Stac3fl/flTgCre skeletal muscles appeared redder
Fig. 7 Myosin-ATPase staining (pH 4.21) of EDL and SOL muscle sections from 8-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. a Representative
images of stained muscle sections. Scale bars: 100 μm. b Percentages of type I and type II myofibers in the EDL muscle. c Percentages of type I and type
II myofibers in the SOL muscle. Values not sharing the same letter labels are different (P< 0.05, n= 4 mice)
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Fig. 8 NADH-TR staining of EDL and SOL muscle sections from 8-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. a Representative images
of NADH-TR staining. Scale bars: 100 μm. b Percentages of light-stained and dark-stained myofibers in the EDL muscles. c Percentages of light-stained
and dark-stained myofibers in the SOL muscles. Values not sharing the same letter labels are different (P < 0.05, n = 4 mice)
Table 1 Relative expression levels of selected mRNAs in left hindlimb muscles of mice 4 weeks after tamoxifen injection
Gene Fiber type Stac3fl/fl Stac3+/flTgCre Stac3fl/flTgCre
Actn3 II 799.4 ± 232.6a 6040.1 ± 1281.6b 22679.4 ± 4486.4c
Myh1 II 569.0 ± 126.4a 747.1 ± 129.2ab 1472.3 ± 146.5b
Myh2 II 769.9 ± 188.9 1124.7 ± 163.5 1373.4 ± 140.1
Myh4 II 17463.2 ± 976.8a 11812.9 ± 1427.3ab 8553.5 ± 1702.5b
Tnnt3 II 104459.0 ± 32168.1a 42788.0 ± 7435.6b 29655.8 ± 4040.2b
Mb I 6.8 ± 0.8a 8.3 ± 0.6ab 10.2 ± 0.4b
Mef2c I 1531.8 ± 336.6a 501.6 ± 129.1b 898.8 ± 69.1a
Myh7 I 35.6 ± 2.6a 42.1 ± 9.0a 85.6 ± 9.9b
Ppargc1a I 50.5 ± 7.7a 136.8 ± 35.2b 118.1 ± 16.6b
Tnnt1 I 52.2 ± 3.9a 70.5 ± 21.0a 155.3 ± 16.1b
Myh3 Fetal or regenerating 1.3 ± 0.5a 0.7 ± 0.1a 39.1 ± 10.8b
Myh8 Perinatal or regenerating 5.2 ± 1.0a 4.0 ± 0.6a 12.2 ± 2.6b
Actn3 alpha actinin 3, Myh myosin heavy chain, Tnnt3 troponin T type 3, Mb myoglobin, Mef2c myocyte-specific enhancer factor 2C, Ppargc1a peroxisome
proliferator-activated receptor gamma coactivator 1 alpha, Tnnt1 troponin T type 1. Data =mean ± SEM (n = 4 or 5 mice). a,b,c Values not sharing the same letter la-
bels are different for the same gene (P < 0.05).
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stimulated (100 Hz), but these increases were not different
between the two genotypes (Fig. 12c).
Postnatal Stac3 deletion reduced protein expression of
RYR1 in skeletal muscle
The DHPRα1 subunit CACNA1S (also known as Cav1.1)
and RYR1 are essential for EC coupling. We compared
the expression levels of these two proteins in hindlimb
muscles from Stac3fl/flTgCre and Stac3fl/fl mice at 8 weeks
of age, i.e., 4 weeks after tamoxifen injection, by western
blotting analyses. The expression level of RYR1 was nearly
50 % less in Stac3fl/flTgCre than in Stac3fl/flTgCre mice
(Fig. 13, P < 0.05). The expression level of CACNA1S was
30 % less in Stac3fl/flTgCre than in Stac3fl/flTgCre mice
(Fig. 13, P = 0.10).
Discussion
In this study, we characterized the effects of postnatal
Stac3 deletion on skeletal muscle growth, fiber compos-
ition, and contractile responses in mice. We deleted the
Stac3 gene in postnatal mice through the Flp-FRT and
tamoxifen-inducible Cre-loxP recombination systems
[8, 9]. At the mRNA level, Stac3 expression in skeletal
muscle was reduced to nearly none 4 weeks after tamoxi-
fen injection. This low expression indicates that the floxed
Stac3 gene was efficiently excised by tamoxifen-induced
Cre recombinase in skeletal muscle. However, at the pro-
tein level, STAC3 expression in skeletal muscle was re-
duced by 70 % 4 weeks after tamoxifen injection, which
was less than that observed for Stac3 mRNA. This dis-
crepancy was perhaps caused by the STAC3 protein being
very stable or the translation of Stac3 mRNA into STAC3
protein being very efficient in mouse skeletal muscle.
Nevertheless, the phenotypic changes in Stac3-deleted
mice suggest that a 70 % reduction in STAC3 protein
expression is sufficient to alter the functions of this
protein in mouse skeletal muscle.
Our data showed that postnatal Stac3 deletion caused
several significant phenotypic changes in skeletal muscle.
One change was reduced skeletal muscle growth. Histo-
logical analyses showed that the skeletal muscle of
Stac3-deleted mice had a smaller CSA but a similar
number of myofibers compared to that of control mice.
These data suggest that STAC3 is needed for normal
myofiber hypertrophy in postnatal mice. Myofiber hyper-
trophy results from increased protein synthesis and
reduced protein degradation. The IGF1-IGFIR-PI3K-
Akt/PKB-mTOR and the myostatin-ACTRII-Smad2/3
are two primary signaling pathways that regulate protein
accumulation, positively and negatively, respectively, in
Fig. 9 Muscle strength analysis of Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice before and after tamoxifen injection. Muscle strength was assessed
by grip strength and grip time tests at 4, 5, 6, 7, and 8 weeks of age. Mice received tamoxifen injection on the first 5 days of week 5 of
age. a Grip strength. b Grip strength normalized to body mass. c Grip time. d Grip time normalized to body mass. Values not sharing the same letter
labels are different at the same age (P < 0.05, n = 4 mice)
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the skeletal muscle [18, 19]. It remains to be determined
if Stac3 deletion inhibits muscle hypertrophy by influen-
cing these signaling pathways.
The second phenotypic change in Stac3-deleted muscle
was an increased number of myofibers containing central-
ized nuclei. The histological analyses indicated that these
centrally nucleated myofibers were among the smallest fibers
in the muscles analyzed. Stac3-deleted skeletal muscle had
an increased expression of Myh3 and Myh8 mRNAs. Since
these two myosin heavy chain genes are typically expressed
in fetal and neonatal muscle or regenerating adult muscle
[16, 17], the increased myofibers with centralized nuclei in 8-
week-old Stac3-deleted mice represent either those from the
fetal or neonatal stage or regenerating myofibers in adult
muscle. Interestingly, embryonic Stac3 deletion caused the
majority of myofibers in newborn mice to have centralized
nuclei [1]. It remains to be determined if the increased
myofibers with centralized nuclei in 8-week-old Stac3-de-
leted mice result from retarded myofiber growth or myofi-
ber regeneration.
The third phenotypic change caused by postnatal
Stac3 deletion was a muscle fiber-type switch. Post-
natal Stac3 deletion increased the percentage of
type I fibers in the fast twitch EDL muscle and the
oxidative capacity in the slow twitch SOL muscle.
Since Stac3 deletion did not alter the total number
of myofibers in these muscles, the increase in type
I or oxidative fibers suggests that Stac3 deletion
inhibited the type I to type II transition in fast
twitch muscle while stimulating the glycolytic to
Fig. 10 Electrostimulation-induced contractions in EDL and SOL muscles from tamoxifen-injected Stac3fl/fl and Stac3fl/flTgCre mice at 8 weeks of
age. a Representative twitch (1 Hz) and tetanic (150 Hz) contractile responses. b Stress-frequency relationships. Frequencies of electrostimulation
used were 1, 30, 50, 80, 100, and 150 Hz. Force was normalized to the average cross-sectional area of the muscle to yield stress (mN/mm2). Asterisks
indicate P < 0.05, Stac3fl/flTgCre versus Stac3fl/fl at the same frequency (n = 4 mice for Stac3fl/fl; n = 5 mice for Stac3fl/flTgCre)
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Fig. 11 Caffeine-induced contractions in EDL and SOL muscles from tamoxifen-injected Stac3fl/fl and Stac3fl/flTgCre mice at 8 weeks of age. The
EDL and SOL muscles from mice 4 weeks after tamoxifen injection were stimulated by 25 mM caffeine. a Representative contractile responses.
Black arrows indicate addition of caffeine. b Summary stress (mN/mm2) responses. Values are not different (P > 0.05) between Stac3fl/fl and
Stac3fl/flTgCre (n = 4 mice for Stac3fl/fl; n = 5 mice for Stac3fl/flTgCre)
Fig. 12 Electrostimulation- and caffeine-induced increases in intracellular calcium in FDB myofibers from tamoxifen-injected Stac3fl/fl and Stac3fl/flTgCre mice at
8 weeks of age. The FDB myofibers from mice 4 weeks after tamoxifen injection were loaded with the fluorescent calcium indicator Fura-4F. Fluorescence
emission was recorded by a microscope. a Representative raw Fura-4F traces. b Quantification of frequent electrostimulation-induced increases in intracellular
calcium concentration. Asterisks indicate P< 0.05, Stac3fl/flTgCre versus Stac3fl/fl at the same frequency (n= 37, 18 fibers for Stac3fl/flTgCre and Stac3fl/fl, respectively).
c Quantification of caffeine-induced percentage changes in intracellular calcium concentration. Asterisk indicates P < 0.05, Stac3fl/flTgCre versus Stac3fl/fl
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oxidative fiber transition in slow twitch muscle.
Such an effect of Stac3 deletion on fiber-type
switch is supported by the facts that Stac3-deleted
limb muscles in general had greater expression of
genes marking type I fibers and less expression of
genes marking type II fibers than control limb
muscles and that Stac3-deleted muscles appeared
redder and had greater expression of myoglobin
mRNA than control muscles.
The fourth phenotypic change caused by postnatal Stac3
deletion in mice was reduced muscle force production. Both
grip strength and grip time tests indicated that beginning the
first week after tamoxifen injection, muscle strength was
reduced in Stac3-deleted mice and that this reduction was
not recovered 4 weeks after tamoxifen injection. Both grip
strength and grip time in Stac3-deleted mice were less
than those in control mice after being normalized to body
mass. This data suggests the Stac3 deletion-caused reduc-
tion in muscle grip strength was not due to reduction in
muscle size. Muscle contractile function tests showed that
electrostimulation-induced maximum stress was smaller
in Stac3-deleted compared to control muscle. Because
stress was muscle force normalized to CSA, this data fur-
ther suggested that the decreased muscle size was not re-
sponsible for the reduced contractile forces.
In this study, we found that postnatal Stac3 deletion re-
duced electrostimulation- but not caffeine-induced muscle
contractions and calcium release from the sarcoplasmic
reticulum (SR). This finding is consistent with earlier stud-
ies in Stac3-deleted mouse fetuses and Stac3-mutated zeb-
rafish [2, 3]. In this study, we found that the total cellular
expression of RYR1 and, to a lesser degree, that of CAC-
NA1S, were reduced in skeletal muscle of Stac3-deleted
postnatal mice compared to control mice. Reduced ex-
pressions of CACNA1S and RYR1 were also ob-
served in the skeletal muscle of Stac3-deleted fetal
mice [2]. These observations suggest that Stac3
deletion might affect electrostimulation-induced
calcium release from the SR and contraction in
part by reducing the expression and/or the stabil-
ity of RYR1 and CACNA1S proteins in the skeletal
muscle. A recent study by Polster et al. demon-
strates that STAC3 can target the DHPRα1 subunit
CACNA1S to the plasma membrane of tsA201
cells [4]. In this study, we did not determine if
Stac3-deleted skeletal muscle lacked CACNA1S on
the sarcolemma or T-tubules, but a T-tubular defi-
ciency of CACNA1S would explain why Stac3-deleted
muscle was deficient in electrostimulation-induced
calcium release from the SR and contraction. A
sarcolemma-specific reduction of CACNA1S expres-
sion in adult mice has been shown to cause muscle
atrophy without affecting EC coupling [20]. Thus, a
sarcolemmal deficiency of CACNA1S expression
would explain our observation that Stac3 deletion
inhibited muscle hypertrophy in young mice. The
Fig. 13 Western blotting analyses of CACNA1S and RYR1 in hindlimb muscles from tamoxifen-injected Stac3fl/fl and Stac3fl/flTgCre mice at 8 weeks
of age. a Representative western blots. Hindlimb muscles from three mice for each genotype were analyzed. Beta tubulin (TUBB) was detected as
the loading control. Molecular markers are shown in the first lane. b Quantification of band intensities. Intensity of the CACNA1S or RYR1 band
was normalized to that of the TUBB band in the same sample. Asterisk: P < 0.05, Stac3fl/flTgCre versus Stac3fl/fl
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attenuated muscle stress responses in Stac3-deleted
muscle to electrostimulation could be also due to de-
fective membrane depolarization, defective voltage-
dependent activation of DHPR, and/or deficient
DHPR-RYR1 coupling. These possibilities remain to be
characterized in the future. In this study, we also found
that Stac3-deleted myofibers had a greater release of
calcium from the SR in response to the ryanodine re-
ceptor agonist caffeine compared to control myofibers.
This result suggests that Stac3 deletion might increase
the sensitivity of RYR1 to caffeine or the amount of re-
leasable calcium in the SR.
Muscle activity can affect both muscle size and fiber type
[21, 22]; thus, it is tempting to speculate that Stac3
deletion-induced changes in fiber size and type were
secondary to changed muscle activity. Increased muscle
activity generally contributes to fiber hypertrophy,
whereas reduced muscle activity could result in muscle
atrophy, perhaps through the calcium/calcineurin sig-
naling pathway [23, 24]. As such, it is possible that
Stac3 deletion-reduced muscle contraction is respon-
sible for reduced fiber growth. However, the same
mechanism may not be responsible for Stac3 deletion-
caused type II to type I fiber transformation because
reduced muscle activity usually leads to type I to type
II fiber switch [25]. The STAC3 protein contains a
SH3 domain, and through this domain, STAC3 could
interact with and affect the expression, location, or
function of many proteins [26]. Therefore, it is possible
that STAC3 mediates EC coupling, fiber-type switch, and
fiber hypertrophy through different protein partners.
Conclusions
This study demonstrates that Stac3 is important to fiber
growth, fiber-type composition, contractile responses,
and electrostimulation-induced release of calcium ions
from the sarcoplasmic reticulum in postnatal skeletal
muscle and that the role of STAC3 in skeletal muscle
may be beyond the process of EC coupling. Since Stac3
knockout is embryonically lethal, the postnatal Stac3
knockout mouse generated in the present study will be a
more convenient model for understanding the role of
STAC3 in skeletal muscle physiology and disease and
the underlying cellular and molecular mechanisms.
Additional files
Additional file 1: Table S1. Nucleotide sequences of primers used in
this study. Table S2. Contractile properties of EDL and SOL muscles from
8-week-old Stac3fl/fl and Stac3fl/flTgCre mice. (DOCX 18 kb)
Additional file 2: Figure S1. Histological analysis of EDL muscles from
4-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. Cross-sections of
EDL muscles were stained with hematoxylin and eosin. a Representative
images of stained EDL sections at ×40 and ×400 magnifications. Scale
bars: 100 μm for ×40 and 10 μm for ×400. Arrows point to myofibers with
centralized nuclei. b Average number of myofibers per cross-section. This
number was not different between genotypes. c Average cross-sectional
area (CSA) of myofibers. d Distribution of CSA of myofibers. e Percentage
of myofibers containing centralized nuclei. (TIF 74102 kb)
Additional file 3: Figure S2. Histological analysis of SOL muscles from
4-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre mice. Cross-sections of
SOL muscles were stained with hematoxylin and eosin. a Representative
images of stained SOL sections at ×40 and ×400 magnifications. Scale
bars: 100 μm for ×40 and 10 μm for ×400. Arrows point to myofibers with
centrally located nuclei. b Average number of myofibers per cross-section.
This number was not different between genotypes. c Average cross-sectional
area (CSA) of myofibers. d Distribution of CSA of myofibers. e Percentage of
myofibers containing centralized nuclei. (TIF 73696 kb)
Additional file 4: Figure S3. Myosin-ATPase staining (pH 4.21) of cross-
sections of EDL and SOL muscles from 4-week-old Stac3fl/fl, Stac3+/flTgCre,
and Stac3fl/flTgCre mice before tamoxifen injection. a Representative images
of stained muscle sections. Scale bars: 100 μm. b Percentages of type I and
type II myofibers in EDL muscles. c Percentages of type I and type II
myofibers in SOL muscles. None of the percentages are different between
genotypes (n = 4 mice). (TIF 50091 kb)
Additional file 5: Figure S4. NADH-TR staining of cross-sections of EDL
and SOL muscles from 4-week-old Stac3fl/fl, Stac3+/flTgCre, and Stac3fl/flTgCre
mice before tamoxifen injection. a Representative images of NADH-TR
staining. Scale bars: 100 μm. b Percentages of light-stained and dark-stained
myofibers in EDL muscles. c Percentages of light-stained and dark-stained
myofibers in SOL muscles. None of the percentages are different between
genotypes (n = 4 mice). (TIF 51536 kb)
Additional file 6: Figure S5. Quantification of electrostimulation-
induced increases in intracellular calcium concentration in FDB myofibers
from tamoxifen-injected Stac3fl/fl and Stac3fl/flTgCre mice at 8 weeks of age.
The FDB myofibers from mice 4 weeks after tamoxifen injection were
loaded with the fluorescent calcium indicator Fura-2. Fluorescence emission
was recorded by a microscope. Asterisks indicate P < 0.05, Stac3fl/flTgCre versus
Stac3fl/fl at the same frequency (n = 8 fibers each genotype). (TIF 9896 kb)
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